Maria Siemionow
Fundador en Dystrogen Therapeutics Corp. .
Cargos activos de Maria Siemionow
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Dystrogen Therapeutics Corp.
 Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Director Técnico/Científico/I+D | 01/01/2017 | - |
| Fundador | 01/01/2017 | - |
Historial de carrera de Maria Siemionow
Antiguos cargos conocidos de Maria Siemionow.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Tolera Therapeutics, Inc.
 Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Director Técnico/Científico/I+D | 20/09/2010 | - |
| Fundador | 20/09/2010 | - |
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectorial
| Commercial Services | 2 |
| Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Commercial Services |
Dystrogen Therapeutics Corp.
Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Technology Services |
- Bolsa de valores
- Insiders
- Maria Siemionow
- Experiencia
